Unicycive Therapeutics Announces Second Quarter 2026 Financial Results And Provides Business Update
UNCY•Second-quarter results and business update
Aug. 12 (Reuters) - Unicycive Therapeutics Inc. UNCY.O:
- Unicycive Therapeutics announces second quarter 2026 financial results and provides business update.
- Unicycive Therapeutics - Q2 net loss was $1.70 million, or $0.06 per share.
Source text: ID:nGNXb4whq1
Further company coverage: UNCY.O
